Shattuck Labs Announces Participation in Citi’s 2021 Virtual Immuno-Oncology Day

NEXT STORY
Revive Therapeutics Announces Closing of $23.0 Million Short Form Prospectus Offering
PREV STORY
Corvus Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Autolus Therapeutics announces publication of obe-cel (AUTO1) Phase 1 ALLCAR19 data in adults with relapsed/ refractory B-ALL in Journal of Clinical Oncology

author_avatar
NASDAQ Market News

Tarsus Pharmaceuticals, Inc. Reports Third Quarter 2021 Financial Results and Recent Business Achievements

author_avatar
NASDAQ Market News

Genenta Announces Pricing of Upsized Initial Public Offering

author_avatar
NASDAQ Market News